AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

The Chicago Bears still have time to address their need at edge rusher and one analyst has them signing an eight-time Pro Bowler to do so. The Chicago Bears should not be done in free agency. As has ...

Johnson & Johnson's Tecvayli has been approved as part of a combination regimen with its Genmab-partnered Darzalex Faspro as a second-line therapy for relapsed or refractory multiple myeloma, just 55 ...

Learn what it takes to invest in gold and silver Michael is a former senior editor of investing and trading products for Investopedia. He has 20+ years of mutual fund, macro market research, ...

Subscribe to our FREE Newsletter, or Telegram and WhatsApp channels for the latest stories and updates. A foreign couple suspected of cutting queue at a convenience store sparked public anger and got ...

The presidents of the National Academy of Sciences, National Academy of Engineering, and National Academy of Medicine have issued a statement about the value of the National Science Board — which for ...

David Lumb is a managing editor for the mobile team, covering mobile and gaming spaces. Over the last decade, he's reviewed phones for TechRadar as well as covered tech, gaming, and culture for ...

And when it doesn’t by Andrei Hagiu and Julian Wright Many executives and investors assume that it’s possible to use customer-data capabilities to gain an unbeatable competitive edge. The more ...

Apple reported strong quarterly revenue as iPhone demand surged, but questions remain around AI strategy, rising costs, and leadership changes. If you can only read one tech story a day, this is it.

If you could save lives by producing vaccines in transgenic bananas, would you? In the debate over large-scale commercialization and use of GMOs, where should we draw the line? Vaccines Tobacco ...